Chemical Component Summary

Name4-azanyl-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one
Identifiers4-azanyl-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one
FormulaC22 H30 N6 O2
Molecular Weight410.513
TypeNON-POLYMER
Isomeric SMILESCCCCOc1nc(c2c(n1)N(CC(=O)N2)Cc3cccc(c3)CN4CCCC4)N
InChIInChI=1S/C22H30N6O2/c1-2-3-11-30-22-25-20(23)19-21(26-22)28(15-18(29)24-19)14-17-8-6-7-16(12-17)13-27-9-4-5-10-27/h6-8,12H,2-5,9-11,13-15H2,1H3,(H,24,29)(H2,23,25,26)
InChIKeyVFOKSTCIRGDTBR-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count60
Chiral Atom Count0
Bond Count63
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB12687 
NameVesatolimod
Groups investigational
DescriptionVesatolimod has been used in trials studying the treatment of Hepatitis B and Chronic Hepatitis B.
SynonymsVesatolimod
Categories
  • Anti-Infective Agents
  • Antiviral Agents
  • Heterocyclic Compounds, Fused-Ring
  • Toll-Like Receptor 7, agonists
CAS number1228585-88-3

Related Resource References

Resource NameReference
Pharos CHEMBL2424780
PubChem 46241268
ChEMBL CHEMBL2424780